MiR-129 inhibits cell proliferation and metastasis by targeting ETS1 via PI3K/AKT/mTOR pathway in prostate cancer
Xu, Song, Ge, Jingping, Zhang, Zhengyu, Zhou, WenquanVolume:
96
Language:
english
Journal:
Biomedicine & Pharmacotherapy
DOI:
10.1016/j.biopha.2017.10.037
Date:
December, 2017
File:
PDF, 1.45 MB
english, 2017